BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7679811)

  • 1. Molecular matching for clinical kidney transplantation.
    Takemoto S; Terasaki PI; Maruya E; Park MS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):206. PubMed ID: 7679811
    [No Abstract]   [Full Text] [Related]  

  • 2. Revisiting HLA matching for kidney transplantation.
    Opelz G; Wujciak T; Mytilineos J; Scherer S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):173-5. PubMed ID: 8438263
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissection of the respective importance of HLA-A,B,DR matching in 3,789 prospective kidney transplants.
    Hors J; Busson M; Bouteiller AM; Raffoux C; Betuel H; Fauchet R; Tongio MM; Mercier P; Lepetit JC; Dausset J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):687-8. PubMed ID: 3274842
    [No Abstract]   [Full Text] [Related]  

  • 5. Very low frequency of rejection due to HLA-(A+)B+DQ matching.
    Christiaans MH; van den Berg-Loonen PM; Nieman FH; van Hooff JP
    Transplant Proc; 1992 Dec; 24(6):2441-2. PubMed ID: 1465822
    [No Abstract]   [Full Text] [Related]  

  • 6. Proposed HLA matching scheme for improved cadaveric kidney allocation.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S
    Transplant Proc; 1995 Feb; 27(1):61-3. PubMed ID: 7879117
    [No Abstract]   [Full Text] [Related]  

  • 7. Matching for HLA-DPB1 alleles in zero mismatched HLA-A, -B, and -DR renal transplants.
    Middleton D; Mytilineos Y; Savage D; Ferrara GB; Angelini G; Amoroso A; Trainor F; Gaweco A; Mazzola G; Delfino L
    Transplant Proc; 1992 Dec; 24(6):2439-40. PubMed ID: 1361255
    [No Abstract]   [Full Text] [Related]  

  • 8. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
    Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
    Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
    Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
    Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of HLA-A,B matching in cadaver grafts.
    Kilicturgay S; Tokyay R; Turan M; Haberal M
    Transplant Proc; 1992 Oct; 24(5):1678-9. PubMed ID: 1412794
    [No Abstract]   [Full Text] [Related]  

  • 11. Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients.
    Thompson JS; Bryne JE; Hempel HO; Oldfather JW; Green WF; Crowe DO; Sanfilippo F; MacQueen JM; McCalmon RN; Tardiff GN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):251-4. PubMed ID: 8438290
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of HLA-DR incompatibilities on kidney graft function and on the number of rejection treatments. The Dutch Study Group of Renal Transplantation.
    Groenewoud AF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):683-4. PubMed ID: 3274840
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy.
    Persijn GG; D'Amaro J; de Lange P; Schreuder GM; van Rood JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):656-8. PubMed ID: 2650212
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
    Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
    [No Abstract]   [Full Text] [Related]  

  • 15. Cadaveric kidneys should be allocated according to the HLA match.
    Opelz G; Wujciak T
    Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235
    [No Abstract]   [Full Text] [Related]  

  • 16. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
    Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
    [No Abstract]   [Full Text] [Related]  

  • 17. Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
    Cicciarelli J; Terasaki P
    Transplant Proc; 1989 Feb; 21(1 Pt 1):659-60. PubMed ID: 2650213
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-B, DR matching and cadaver renal allograft survival in New England. New England Organ Bank.
    Carpenter CB; Goguen JE; Bradley JW; Turka LA; Cho SI; Milford EL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):663-4. PubMed ID: 2650215
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of kidney transplantation in highly sensitized patients in Scandiatransplant.
    Lamm LU; Madsen M; Fjeldborg D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):729-30. PubMed ID: 3274855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.